Showing 1 posts of 1 posts found.
The Japanese health ministry has approved a study testing the use of induced pluripotent stem (iPS) cells to treat four …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO